result question manag
januari
summari result
lfl sale growth in-lin consensu mark first quarter sinc
 gs top-lin consensu said let us keep perspect
lfl growth still like strong show rel peer shape
top-lin deliveri much consensu expect turn toward bottom-lin
ep beat vs consensu driven ebit margin improv turn
larg driven gross margin improv
highlight believ market grow present previous
revis ep
believ pass peak organ sale growth set slow
coupl stock trade close decad high vs us hpc peer consensu
forward price-to-earnings struggl see attract
maintain under-perform rate target price move
question manag
unilev look like post worst quarter year anticip way
competit respons endeavour right
exan bnpp estim thomson reuter consensu list currenc dividend reinvest
date time london time invest recommend finalis may differ date time broad
dissemin websit see appendix analyst certif import disclosur non-u research analyst disclosur
result question
summari result
lfl sale growth in-lin consensu mark first
quarter sinc gs top-lin consensu said let
us keep perspect lfl growth still like strong show rel
peer shape top-lin deliveri much consensu
expect turn toward bottom-lin ep beat vs consensu
driven ebit margin improv sourc ebit
margin improv reflect increas gross margin
increas sg sale wrt latter made refer
leverag benefit overhead market save
off-set increas market invest inflat
figur outlin main element releas rel
consensu expect
figur summari result rel expect
exan bnp pariba estim consensu per visibl alpha
varianc
 chang number element guidanc figur
outlin main chang
figur summari revis previou guidanc
dividend share buy back
dividend share buy back
highlight main newsworthi item may easili glean
quick read releas
market growth comment believ market growth rate
around present compar market growth rate
 comment upon see market challeng argentina
australia chile hong kong india iraq kenya lebanon mexico nigeria turkey
uk
competit promot level actual see competit
behaviour indic downward price spiral howev note
competitor calendar year base financi year mani
talk increas invest growth may may healthi
price believ current commod price consist current
level price market anticip sea chang environ
would necessit price reduct expect commod cost remain flat
underli perform underli perform busi
headwind follow inventori build japan took place
ahead vat increas addit econom societ impact
market hong kong chile middl east like continu
impact balanc year howev pleas quarter saw
broad base growth gain market share note recent retail sale
trend decemb continu strong
prospect one need rememb chines new year somewhat
earlier like sell-in albeit like immateri
overal context number headwind increas cours
quarter disrupt chile start end quarter also
disrupt lebanon iraq indian market also seen growth slow although
 continu take share final impact cycl
price increas taken previous februari annualis famili
price increas year ago
beauti growth broad base hair skin
sk-ii rel slow quarter given impact vat driven
inventori shift japan civil unrest hong kong
product want make product integr innov
leader product busi unit commit deliv
product believ never previous posit
mani opportun increas product digit tool robot
china optimist futur prospect china lfl
sale growth post
ytd achiev high growth rate skin olay strong
double-digit growth rate feminin double-digit growth
fabric hair busi grew mid- high-singl digit rate
mark best growth china time
us lfl sale growth still strong gain
share month basi categori grew
broadli flat delta growth vs reflect retail inventori reduct
initi time underli us consumpt per scanner data remain
enterpris market growth rate enterpris market border
mid- high-singl digit notwithstand fact two largest
market group india gain share market growth
slow mexico grow mid-singl digit although economi
technic recess
babi busi flat slightli ahead china busi grew
best semest year us flat
improv strong innov plan us
increment innov step chang pace quantum innov
e-commerc e-commerc account around sale current
grow around gs market share e-commerc gener
increas particularli china made signific gain
figur outlin revis previou ep estim
figur summari ep revis
believ pass peak organ sale growth set slow
coupl stock trade close decad high vs us hpc peer
consensu forward price-to-earnings struggl see attract
rate target price
maintain under-perform rate previous argu
trade ep ep see food hpc break
tradit continu employ valuat methodolog light
ep revis target price move
includ save made market expens happen
question manag
unilev look like post worst quarter year anticip
way competit respons endeavour right
suggest unilev appear put sustain innov
suggest would agre
made intend make signific price reduct
comment upon retail destock us pleas give
develop market sale
comment upon attract differenti dividend yield
cost borrow given attract differenti accept
argument embrac leverag undertak greater quantum
hong kong channel remain buoyant market
product
improv anticip come back market
quantif junctur ye pleas give inkl
previous comment skin consum two
prefer area acquisit perspect remain case
improv attract offer trade profit perspect
appear play meaning role renaiss part
function innov abl give quantif raw invest
made trade margin
pass mention seen disrupt travel retail
exclud impact vat driven inventori phase japan hong
kong disrupt seen underli slowdown growth rate sk-ii
anyth give caus concern
super bowl plan advertis perspect
report harri edgewel tie-up could fall foul ftc
someth would surpris see happen
impact sar outbreak upon busi
time ago comment upon desir recruit extern talent
keep mind pleas give colour recent senior
extern hire made
pleas see overleaf revis segment sale profit loss account
fabric
babi feminin famili
profit taxat non-gaap
profit tax
tax pbt
tax pbt non-gaap
profit continu oper non-gaap
profit continu oper
profit discontinu oper
net profit attribut procter gambl
dividend payment prefer share
basic number share averag
fulli dilut number share averag
pay-out ratio basic non-gaap
dividend cover basic non-gaap
chg ebit non-gaap
depreci amortis
chg ebitda non-gaap
invest case valuat risk
believ pass peak organ sale growth set slow
coupl stock trade close decad high vs us hpc peer
consensu forward price-to-earnings struggl see attract
valu ep ep
upsid
risk highlight includ possibl organ sale growth continu
trend stronger rate anticip
downsid
risk highlight includ possibl result competitor respons
organ sale growth start temper faster anticip
cross mikheil omanadz jeff stent heidi vesterinen author contributor report herebi certifi view express report
accur reflect person view compani compani secur discuss report part compens
directli indirectli relat specif recommend view express research report
research analyst name involv prepar research report research analyst exan sa includ exan sa branch base
unit kingdom european econom area switzerland associ person exan inc thu regist qualifi
research analyst financi industri regulatori author finra new york stock exchang nyse non-u analyst subject
nasd rule nyse rule restrict commun subject compani public appear trade secur held research analyst
exan sa regul autorit de contrl prudentiel et de regul acpr autorit de march financi amf franc
exan sa branch base european econom area author regul acpr local relev regul
exan sa geneva branch author regul swiss market supervisori author finma
exan sa london branch subject limit regul financi conduct author detail extent regul financi conduct
author avail us upon request exan inc regul finra secur exchang commiss unit state
research analyst respons prepar report receiv compens base upon variou factor includ overal firm revenu may
